Skip to main content

US ClosedU.S. Closed

SPRC: SciSparc Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules.

52W Range

5thpctl

Volume

0.10×avg

Market Cap

380581USD

P/E Ratio

-0.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

SciSparc Ltd.

SPRCNASDAQ Capital Market·USD·Closed

SciSparc Ltd.

SPRCNASDAQ·USD·Closed

$6.58

−0.60%

$6.58

−$0.04 (0.60%)

52W Range

5thpctl

Volume

0.10×avg

Mkt Cap

380581USD

P/E

-0.0TTM

Div Yield

–ann